| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |